166 related articles for article (PubMed ID: 37758006)
21. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
22. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
Zhang H; Lin X; Zha S
Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
[TBL] [Abstract][Full Text] [Related]
23. Avoid the trap: Targeting PARP1 beyond human malignancy.
Kim C; Chen C; Yu Y
Cell Chem Biol; 2021 Apr; 28(4):456-462. PubMed ID: 33657415
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
25. [Influence of the Poly(ADP-Ribose) Polymerase 1 Level on the Status of Base Excision Repair in Human Cells].
Ilina ES; Kochetkova AS; Belousova EA; Kutuzov MM; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2023; 57(2):285-298. PubMed ID: 37000656
[TBL] [Abstract][Full Text] [Related]
26. Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy.
Peng X; Pan W; Jiang F; Chen W; Qi Z; Peng W; Chen J
Pharmacol Res; 2022 Dec; 186():106529. PubMed ID: 36328301
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of PARP1 Dampens Pseudorabies Virus Infection through DNA Damage-Induced Antiviral Innate Immunity.
Li GL; Ding GX; Zeng L; Ming SL; Fu PF; Wang Q; Yang GY; Wang J; Chu BB
J Virol; 2021 Jul; 95(16):e0076021. PubMed ID: 34037418
[TBL] [Abstract][Full Text] [Related]
28. A Single-Molecule Atomic Force Microscopy Study of PARP1 and PARP2 Recognition of Base Excision Repair DNA Intermediates.
Sukhanova MV; Hamon L; Kutuzov MM; Joshi V; Abrakhi S; Dobra I; Curmi PA; Pastre D; Lavrik OI
J Mol Biol; 2019 Jul; 431(15):2655-2673. PubMed ID: 31129062
[TBL] [Abstract][Full Text] [Related]
29. Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation.
Sriram CS; Jangra A; Kasala ER; Bodduluru LN; Bezbaruah BK
Neurochem Int; 2014 Oct; 76():70-81. PubMed ID: 25049175
[TBL] [Abstract][Full Text] [Related]
30. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.
Demin AA; Hirota K; Tsuda M; Adamowicz M; Hailstone R; Brazina J; Gittens W; Kalasova I; Shao Z; Zha S; Sasanuma H; Hanzlikova H; Takeda S; Caldecott KW
Mol Cell; 2021 Jul; 81(14):3018-3030.e5. PubMed ID: 34102106
[TBL] [Abstract][Full Text] [Related]
31. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
[TBL] [Abstract][Full Text] [Related]
32. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
34. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
Kim IK; Stegeman RA; Brosey CA; Ellenberger T
J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
[TBL] [Abstract][Full Text] [Related]
35. A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity.
Kurgina TA; Anarbaev RO; Sukhanova MV; Lavrik OI
Anal Biochem; 2018 Mar; 545():91-97. PubMed ID: 29326071
[TBL] [Abstract][Full Text] [Related]
36. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
[TBL] [Abstract][Full Text] [Related]
37. PAR recognition by PARP1 regulates DNA-dependent activities and independently stimulates catalytic activity of PARP1.
Deeksha W; Abhishek S; Rajakumara E
FEBS J; 2023 Nov; 290(21):5098-5113. PubMed ID: 37462479
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) polymerase 1 searches DNA via a 'monkey bar' mechanism.
Rudolph J; Mahadevan J; Dyer P; Luger K
Elife; 2018 Aug; 7():. PubMed ID: 30088474
[TBL] [Abstract][Full Text] [Related]
39. PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention.
Zhu X; Ma X; Hu Y
Curr Med Chem; 2016; 23(17):1756-74. PubMed ID: 25245372
[TBL] [Abstract][Full Text] [Related]
40. Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma.
Ferrarotto R; Cardnell R; Su S; Diao L; Eterovic AK; Prieto V; Morrisson WH; Wang J; Kies MS; Glisson BS; Byers LA; Bell D
Head Neck; 2018 Aug; 40(8):1676-1684. PubMed ID: 29570891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
